BMRN vs SD · P/E 40, rev $2.85B vs P/E 6.9, rev $125.3M
Biomarin Pharmaceutical Inc (BMRN) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the BMRN and SD stock pages for the full models.
Not investment advice.